Randomized Clinical Trial to see effects of Yastimadhu Arka eye drop in managing the symptoms of Vataj Abhishyanda (simple allergic conjunctivitis) in comparison to Olopatadine 0.1% eye drop
- Conditions
- Acute atopic conjunctivitis. Ayurveda Condition: VATABISHYANDAH,
- Registration Number
- CTRI/2025/04/085610
- Lead Sponsor
- Dr D Y Patil College of Ayurved and Research Centre.
- Brief Summary
Aim :- To study the efficacy of Yastimadhu Arka Eye drop in the management of Vataja Abhishyanda (Simple Allergic Conjunctivitis).
Sample size - 35 in each arm
Duration of study :- 5 days
Assesment Day - Day 1
Follow up - 3rd and 6th day
The Final conclusion will be drawn on the basis of the statistical analysis based on the observations and result would be interpreted accordingly .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 35
Patients suffering from symptoms of pricking pain , lacrimation , friction of eyelids and signs like congestion and papillae of conjunctiva.
Patients suffering from any other ocular pathology like bacterial conjunctivitis , other types of allergic conjunctivitis , corneal opacity , dacryocystitis and tumors of eye .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of Yastimadhu Arka eye drop in reducing the symptoms of Vataja Abhishyanda(simple allergic conjunctivitis) The assessment of the patient will be done on day 1 , after which the intervention will be provided . Follow up will be taken after 3rd day and finally on 6th day .
- Secondary Outcome Measures
Name Time Method Standardisation of Yastimadhu Arka eye drop . The Secondary outcome will be achieved in 6 weeks after CTRI registration is done .
Trial Locations
- Locations (1)
Dr D Y Patil Ayurved College , Hospital and Research Centre.
🇮🇳Pune, MAHARASHTRA, India
Dr D Y Patil Ayurved College , Hospital and Research Centre.🇮🇳Pune, MAHARASHTRA, IndiaDr Chirag ParmarPrincipal investigator09657652876chirag106258@gmail.com
